Search

everythinglearnresearchcommunity

for

Search:↓

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

A systematic approach is crucial for managing hair loss in women.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

A supplement with Serenoa repens improved hair loss in a patient.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Loose anagen hair can appear at any age and may improve over time.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Analyzing both TE and AA together is crucial for understanding post-COVID-19 hair loss.

Monocytes might be linked to hair loss after COVID-19.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

COVID-19 infection is highly related to increased hair loss, especially in women.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Low vitamin D levels may cause hair loss in women.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Low serum ferritin levels are not closely linked to telogen effluvium in women.